| 0.4 |
1.1 |
GO:0001300 |
chronological cell aging(GO:0001300) |
| 0.2 |
0.7 |
GO:0010897 |
negative regulation of triglyceride catabolic process(GO:0010897) |
| 0.1 |
0.4 |
GO:0050894 |
determination of affect(GO:0050894) |
| 0.1 |
0.5 |
GO:0000412 |
histone peptidyl-prolyl isomerization(GO:0000412) |
| 0.1 |
0.4 |
GO:0070563 |
negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
| 0.1 |
0.3 |
GO:2000502 |
negative regulation of natural killer cell chemotaxis(GO:2000502) |
| 0.1 |
0.5 |
GO:0010989 |
negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 0.1 |
0.4 |
GO:0030223 |
neutrophil differentiation(GO:0030223) |
| 0.1 |
0.3 |
GO:0046122 |
purine deoxyribonucleoside metabolic process(GO:0046122) |
| 0.1 |
0.3 |
GO:0032072 |
plasmacytoid dendritic cell activation(GO:0002270) regulation of restriction endodeoxyribonuclease activity(GO:0032072) negative regulation of apoptotic cell clearance(GO:2000426) |
| 0.1 |
0.2 |
GO:0060738 |
epithelial-mesenchymal signaling involved in prostate gland development(GO:0060738) |
| 0.1 |
0.4 |
GO:0036018 |
cellular response to erythropoietin(GO:0036018) |
| 0.1 |
1.0 |
GO:0030854 |
positive regulation of granulocyte differentiation(GO:0030854) |
| 0.0 |
0.2 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.0 |
0.3 |
GO:0097498 |
endothelial tube lumen extension(GO:0097498) |
| 0.0 |
0.2 |
GO:0061349 |
chemoattraction of serotonergic neuron axon(GO:0036517) planar cell polarity pathway involved in outflow tract morphogenesis(GO:0061347) planar cell polarity pathway involved in ventricular septum morphogenesis(GO:0061348) planar cell polarity pathway involved in cardiac right atrium morphogenesis(GO:0061349) planar cell polarity pathway involved in cardiac muscle tissue morphogenesis(GO:0061350) planar cell polarity pathway involved in pericardium morphogenesis(GO:0061354) chemoattraction of axon(GO:0061642) negative regulation of cell proliferation in midbrain(GO:1904934) planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation(GO:1904955) |
| 0.0 |
0.3 |
GO:0045200 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.0 |
0.2 |
GO:0044837 |
assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 0.0 |
0.0 |
GO:1902162 |
regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
| 0.0 |
0.2 |
GO:0016344 |
meiotic chromosome movement towards spindle pole(GO:0016344) |
| 0.0 |
0.1 |
GO:0030182 |
neuron differentiation(GO:0030182) |
| 0.0 |
0.2 |
GO:0033632 |
regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
| 0.0 |
0.2 |
GO:0044027 |
hypermethylation of CpG island(GO:0044027) |
| 0.0 |
0.1 |
GO:0000349 |
generation of catalytic spliceosome for first transesterification step(GO:0000349) |
| 0.0 |
0.3 |
GO:0098535 |
de novo centriole assembly(GO:0098535) |
| 0.0 |
0.7 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
| 0.0 |
0.2 |
GO:0038018 |
Wnt receptor catabolic process(GO:0038018) |
| 0.0 |
0.5 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 0.0 |
0.6 |
GO:0071803 |
positive regulation of podosome assembly(GO:0071803) |
| 0.0 |
0.1 |
GO:0048852 |
diencephalon morphogenesis(GO:0048852) |
| 0.0 |
0.1 |
GO:0015883 |
FAD transport(GO:0015883) FAD transmembrane transport(GO:0035350) |
| 0.0 |
0.1 |
GO:0036369 |
transcription factor catabolic process(GO:0036369) |
| 0.0 |
0.1 |
GO:0002384 |
hepatic immune response(GO:0002384) |
| 0.0 |
0.6 |
GO:0003376 |
sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.0 |
0.2 |
GO:0051106 |
positive regulation of DNA ligation(GO:0051106) |
| 0.0 |
0.2 |
GO:1904431 |
positive regulation of t-circle formation(GO:1904431) |
| 0.0 |
1.3 |
GO:0045026 |
plasma membrane fusion(GO:0045026) |
| 0.0 |
0.1 |
GO:0015747 |
urate transport(GO:0015747) |
| 0.0 |
0.1 |
GO:0043553 |
negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 0.0 |
0.1 |
GO:0006001 |
fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 0.0 |
0.1 |
GO:0021553 |
olfactory nerve development(GO:0021553) |
| 0.0 |
0.4 |
GO:1900017 |
positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.0 |
0.1 |
GO:0043376 |
regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.0 |
0.1 |
GO:0070091 |
glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
| 0.0 |
0.1 |
GO:0018969 |
thiocyanate metabolic process(GO:0018969) |
| 0.0 |
0.2 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.0 |
0.1 |
GO:0019348 |
dolichol metabolic process(GO:0019348) |
| 0.0 |
0.1 |
GO:0014068 |
positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
| 0.0 |
0.0 |
GO:0010936 |
negative regulation of macrophage cytokine production(GO:0010936) |
| 0.0 |
0.1 |
GO:1904428 |
negative regulation of tubulin deacetylation(GO:1904428) |
| 0.0 |
0.0 |
GO:0031346 |
positive regulation of cell projection organization(GO:0031346) |
| 0.0 |
0.0 |
GO:0070676 |
intralumenal vesicle formation(GO:0070676) |
| 0.0 |
0.1 |
GO:1901873 |
regulation of post-translational protein modification(GO:1901873) |
| 0.0 |
0.1 |
GO:0019075 |
virus maturation(GO:0019075) |
| 0.0 |
0.0 |
GO:0072038 |
mesenchymal stem cell maintenance involved in nephron morphogenesis(GO:0072038) |
| 0.0 |
0.1 |
GO:0032625 |
interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.0 |
0.1 |
GO:0070889 |
platelet alpha granule organization(GO:0070889) |
| 0.0 |
0.1 |
GO:0016598 |
protein arginylation(GO:0016598) |
| 0.0 |
0.0 |
GO:0036324 |
vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 0.0 |
0.2 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 0.0 |
0.4 |
GO:0033234 |
negative regulation of protein sumoylation(GO:0033234) |
| 0.0 |
0.0 |
GO:0090427 |
positive regulation of catagen(GO:0051795) activation of meiosis(GO:0090427) |
| 0.0 |
0.2 |
GO:0048680 |
positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
| 0.0 |
0.1 |
GO:0003193 |
pulmonary valve formation(GO:0003193) foramen ovale closure(GO:0035922) |
| 0.0 |
0.4 |
GO:0007191 |
adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
| 0.0 |
0.2 |
GO:0002315 |
marginal zone B cell differentiation(GO:0002315) |
| 0.0 |
0.0 |
GO:0002856 |
negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) negative regulation of natural killer cell mediated immune response to tumor cell(GO:0002856) negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002859) |
| 0.0 |
0.0 |
GO:1905051 |
regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 0.0 |
0.1 |
GO:1901503 |
ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 0.0 |
0.1 |
GO:1990564 |
protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.0 |
0.1 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.0 |
0.1 |
GO:0006051 |
mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
| 0.0 |
0.1 |
GO:0035936 |
testosterone secretion(GO:0035936) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
| 0.0 |
0.1 |
GO:1900104 |
hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.0 |
0.1 |
GO:0015746 |
tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.0 |
0.0 |
GO:0045083 |
negative regulation of interleukin-12 biosynthetic process(GO:0045083) |
| 0.0 |
0.1 |
GO:0036228 |
protein targeting to nuclear inner membrane(GO:0036228) |
| 0.0 |
0.0 |
GO:0002183 |
cytoplasmic translational initiation(GO:0002183) |
| 0.0 |
0.1 |
GO:2001160 |
regulation of histone H3-K79 methylation(GO:2001160) positive regulation of histone H3-K79 methylation(GO:2001162) |
| 0.0 |
0.1 |
GO:0006014 |
D-ribose metabolic process(GO:0006014) |
| 0.0 |
0.1 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.0 |
0.1 |
GO:0090669 |
telomerase RNA stabilization(GO:0090669) |
| 0.0 |
0.1 |
GO:0032929 |
negative regulation of superoxide anion generation(GO:0032929) |
| 0.0 |
0.1 |
GO:0045872 |
positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.0 |
0.1 |
GO:0006196 |
AMP catabolic process(GO:0006196) |
| 0.0 |
0.1 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
| 0.0 |
0.1 |
GO:0021694 |
cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
| 0.0 |
0.1 |
GO:1903385 |
regulation of homophilic cell adhesion(GO:1903385) |
| 0.0 |
0.1 |
GO:1990928 |
response to amino acid starvation(GO:1990928) |
| 0.0 |
0.1 |
GO:0010796 |
regulation of multivesicular body size(GO:0010796) |
| 0.0 |
0.1 |
GO:1901545 |
cellular response to raffinose(GO:0097403) response to raffinose(GO:1901545) |
| 0.0 |
0.1 |
GO:0090362 |
positive regulation of platelet-derived growth factor production(GO:0090362) |
| 0.0 |
0.1 |
GO:0033123 |
positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
| 0.0 |
0.1 |
GO:0090070 |
positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.0 |
0.1 |
GO:1900147 |
Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
| 0.0 |
0.1 |
GO:2001288 |
positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.0 |
0.1 |
GO:0030242 |
pexophagy(GO:0030242) |
| 0.0 |
0.1 |
GO:1904578 |
response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
| 0.0 |
0.1 |
GO:0044565 |
dendritic cell proliferation(GO:0044565) |
| 0.0 |
0.0 |
GO:0072678 |
T cell migration(GO:0072678) |
| 0.0 |
0.0 |
GO:0090080 |
positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 0.0 |
0.0 |
GO:0038193 |
thromboxane A2 signaling pathway(GO:0038193) |
| 0.0 |
0.1 |
GO:0061669 |
spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
| 0.0 |
0.0 |
GO:0006272 |
leading strand elongation(GO:0006272) |
| 0.0 |
0.2 |
GO:0034498 |
early endosome to Golgi transport(GO:0034498) |
| 0.0 |
0.1 |
GO:0000972 |
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
| 0.0 |
0.1 |
GO:2000622 |
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.0 |
0.1 |
GO:0061502 |
early endosome to recycling endosome transport(GO:0061502) |
| 0.0 |
0.0 |
GO:0010863 |
positive regulation of phospholipase C activity(GO:0010863) regulation of phospholipase C activity(GO:1900274) |
| 0.0 |
0.0 |
GO:0071774 |
response to fibroblast growth factor(GO:0071774) |
| 0.0 |
0.0 |
GO:0072720 |
response to dithiothreitol(GO:0072720) |
| 0.0 |
0.2 |
GO:0000479 |
endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |